Grupo Biotoscana company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

grupobiotoscana.com

Founded Year

1987

Stage

Acq - P2P | Acquired

Valuation

$0000 

About Grupo Biotoscana

Grupo Biotoscana (GBIO33) is a pharmaceutical multinational company, provides pharma, biological, hospital, oncological, and generic products.On November 29th, 2019, Grupo Biotoscana was acquired by Knight Therapeutics.3M.

Grupo Biotoscana Headquarter Location

Dr Luis Bonavita 1294, #2004

Montevideo, 11300,

Uruguay

+598 2626 2344

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Grupo Biotoscana

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Grupo Biotoscana is included in 1 Expert Collection, including Cancer.

C

Cancer

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

Latest Grupo Biotoscana News

Knight Therapeutics’ Acquisition of remaining 48,79 % in Biotoscana

Sep 21, 2020

Davies Ward Phillips & Vineberg, Pinheiro Neto, Bonn Steichen & Partners and Lobo de Rizzo advised on the transaction Knight Therapeutics Inc. (TSX: GUD) and its wholly owned subsidiary 1178991 CANADA INC. completed the tender offer process filed by 1178991 CANADA INC. for the acquisition and delisting of all outstanding Brazilian Depositary Receipts of Biotoscana Investments S.A. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a pan-American (ex-US) specialty pharmaceutical company focused on developing, acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Knight owns a controlling stake in Grupo Biotoscana, a pan-Latin American specialty pharmaceutical company. Davies Ward Phillips & Vineberg advised Knight Therapeutics Inc. with Hillel W. Rosen (Picture), Brian Kujavsky, Shayna Goldman and Julia Knafo. In Brazil, Pinheiro Neto advised Knight Therapeutics Inc. with Guilherme Sampaio Monteiro, Milena Casado de Oliveira, Marcelo Junqueira de Mello, Taisa Sani and Letícia Fonseca Marcondes Venancio. In Brazil, Lobo de Rizzo Advogados advised Advent International and Essex Woodlands

  • When was Grupo Biotoscana founded?

    Grupo Biotoscana was founded in 1987.

  • Where is Grupo Biotoscana's headquarters?

    Grupo Biotoscana's headquarters is located at Dr Luis Bonavita 1294, #2004, Montevideo.

  • What is Grupo Biotoscana's latest funding round?

    Grupo Biotoscana's latest funding round is Acq - P2P.

  • Who are the investors of Grupo Biotoscana?

    Investors of Grupo Biotoscana include Knight Therapeutics.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.